Login to Your Account



New UK early access drugs program sets stage for wider reforms

By Nuala Moran
Staff Writer

Monday, April 28, 2014
LONDON – The first deadline is approaching for submissions to a new UK Early Access to Medicines Scheme (EAMS), designed to support access to unlicensed or off-label drugs in areas of unmet medical need.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription